+Vote!
Business Wire (Free subscription) | 25/11/2008
CHICAGO--(BUSINESS WIRE)--William Blair & Company initiated research coverage of Genoptix, Inc. (Nasdaq:GXDX) ($29.51), a specialty lab focused on the hematopathology (diagnosis of blood-based diseases) market,
+Vote!
The Huffington Post (Free subscription) | 21 hours ago
Through the turbulent trials of Wall Street, Chicago's leading private investment firm, William Blair & Co., has managed to stay in the quiet eye of the storm. The firm avoided the siren call of mortgage-backed securities, completed several high profile mergers and acquisitions in the past year, and is hiring as its competitors lay off employees. William Blair's vice chairman,...
+Vote!
Reuters UK (Free subscription) | yesterday
D.J. Neiman, an analyst at William Blair & Co, also cited some concerns in the market about Janus' debt level and its covenants. "My opinion is Janus is fine, at least in the near term. The have enough cash and generate enough cash to cover their interest payments," he said.
+Vote!
BabeofBusiness.com (Free subscription) | 30/11/2008
... parents’ money); spending about $200 billion annually, according to Chicago-based investment firm William Blair & Co. Most ethnically diverse market U.S. history Born wired and Internet-enabled Deep love for technology in all its forms Lack brand loyalty and will switch at the drop of a hat Thrive on change and look for new features and models to be introduced quickly Have been nurtured...
+Vote!
Business Wire (Free subscription) | 24/11/2008
CINCINNATI--(BUSINESS WIRE)--Wal-Mart Stores (NYSE: WMT) has edged higher this afternoon, with a little help from an upgrade at William Blair from "market perform" to "outperform." As it stands now, there isn't a lot